The 20 Best Diffuse Midline Glioma H3 K27M-Mutant Doctors Near Me in Fairfax, VA

Mather Director, Radiation Oncology Research Inova Radiation Oncology Inova Schar CancerDr. Avani Rao is a specialty care physician board certified in radiation oncology who serves as the Director of Research, Proton Therapy Fellowship Director and lead physician in pediatric radiation oncology. She joined Radiation Oncology Associates in 2020. Her areas of interest are pediatric, gynecologic, gastrointestinal and breast malignancies.Dr. Rao graduated from Yale University magna cum laude with a bachelor’s degree in molecular, cellular and developmental biology. She completed medical school, her internal medicine internship and her radiation oncology residency at Johns Hopkins School of Medicine. She was nominated to Alpha Omega Alpha during medical school, and during her residency, Dr. Rao served as Chief Resident. She pursued additional fellowship training at the University of Maryland to gain specific expertise in proton therapy. Dr. Rao has received several awards supporting her research and recognizing her clinical excellence and has published more than 40 peer-reviewed publications. Dr. Rao is board certified in radiation oncology. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Dr. Lonika Majithia is currently the Medical Director of Brachytherapy and Director of Educational Programs at Radiation Oncology Associates, and is board certified in radiation oncology. She joined Radiation Oncology Associates in 2016. Her clinical interests include gynecologic, breast, CNS, GI, thoracic and hematologic malignancies. Dr. Majithia is experienced with multiple radiotherapy techniques including volumetric modulated arc therapies (VMAT), intensity modulated radiation therapy (IMRT), stereotactic body radiotherapy, Gamma Knife and CyberKnife Radiosurgery, intra-operative radiotherapy (IORT), eye plaque brachytherapy, and prostate and gynecologic brachytherapy, including High Dose Rate (HDR) brachytherapy. Dr. Majithia grew up in Albuquerque, NM. She graduated magna cum laude from the University of New Mexico with dual bachelor’s degrees in biology and physics. She was awarded the UNM Merit Scholarship and actively participated in physics and basic science research. She completed her medical training at the University of New Mexico where she was elected to the Alpha Omega Alpha Medical Honor Society. She completed her preliminary medicine internship at the Medical College of Wisconsin in Milwaukee, WI and her radiation oncology residency at The Ohio State University in Columbus, OH. She served as Chief Resident during her last year of residency and remained active in academic pursuits including research and medical education. During her residency, she presented multiple abstracts and presentations at the American Society for Radiation Oncology (ASTRO) annual meetings and American Society of Clinical Oncology (ASCO) meetings. She has published book chapters, written retrospective review articles, and assisted in the development of a phase I clinical trial in hematologic malignancies. During her residency, she also completed a master’s degree in medical sciences. Dr. Majithia is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Metastatic Brain Tumor, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer.

Dr. C. Bryce Johnson is a specialty care physician board certified in radiation oncology. He joined Inova Health System in 2021 and has been practicing since 2017. Prior to joining Inova, Dr. Johnson completed his radiation oncology residency at Memorial Sloan Kettering Cancer Center. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Metastatic Brain Tumor, Pleuropulmonary Blastoma, and Familial Prostate Cancer.

Dr. Daniel Kim is a specialty care physician board certified in radiation oncology at Inova Health System. Dr. Kim graduated top of his class from Amherst College with degrees in neuroscience and music, while becoming a four-time All-American tennis athlete and winning the NCAA men’s tennis championship. He graduated with his MD and MBA, with honors, from Harvard. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Meningioma, and Prostatectomy.

Mather Chair, Radiation Oncology Department Chair and System Division Chief, Inova Radiation Oncology Inova Schar CancerDr. Ashish Chawla is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2011.He received his undergraduate degree from Pennsylvania State University, graduating with honors in biology. He received his medical degree from Thomas Jefferson University in Philadelphia in 1998, where he was elected to the prestigious Alpha Omega Alpha Medical Honor Society. He completed his radiation oncology training at Harvard’s Massachusetts General Hospital in 2003. There, he won awards for scholarly research as a radiation oncology resident. He has published several peer-reviewed articles related to breast, prostate and gastrointestinal cancer management.Prior to joining Radiation Oncology Associates, he served as a radiation oncologist at Anne Arundel Medical Center in Annapolis, MD. There, he helped lead innovative clinical research as the principal investigator for breast cancer protocols with the Radiation Therapy Oncology Group. He also helped lead the cancer center’s stereotactic radiosurgery program and served as cancer liaison for the American College of Surgeons’ Commission on Cancer. He led numerous studies involving partial breast irradiation as well as prostate, central nervous system, and head and neck cancer investigations.Dr. Chawla’s clinical interests include the multidisciplinary management of breast cancer and prostate cancer patients, and he is the Director of the Partial Breast Irradiation Program at Inova Fairfax Hospital. He has expertise in the use of stereotactic radiosurgery and stereotactic body radiotherapy for tumors of the brain, spine and lung. Additional areas of clinical interest include gastrointestinal, lung, head and neck, and brain tumors.Dr. Chawla has been listed in Washingtonian magazine, Northern Virginia Magazine, and U.S. News and World Report as “Top Doctor” for radiation oncology in the Washington, DC, and Northern Virginia areas. Dr. Chawla is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Prostate Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.

Dr. Kevin Choe is a specialty care physician board certified in radiation oncology at Inova Health System. He joined Inova in 2015 and has been practicing since 2005. Prior to joining Inova, Dr. Choe was on the faculty at University of Texas, Southwestern Medical Center in Dallas, TX, where he specialized in high-precision stereotactic radiotherapy. His research focused on elucidating the genetic alterations that contribute to cancer development and progression. He also designed and conducted clinical trials, investigating novel strategies to overcome treatment resistance in aggressive and metastatic cancers. Dr. Choe grew up in Fairfax, VA, and appreciates the opportunity to serve the community he cares deeply for. Dr. Choe is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Hasan Syed is a Neurologist practicing medicine in Fairfax, Virginia. Dr. Syed is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Hydrocephalus, Pineocytoma, Craniosynostosis, Spinal Fusion, and Laminectomy.

John Myseros is a Neurosurgery provider practicing medicine in Fairfax, Virginia. Dr. Myseros is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Craniosynostosis, Chiari Malformation Type 2, Chiari Malformation, Posterior Fossa Decompression, and Osteotomy.

Dr. Sarah Gao is a specialty care physician board eligible in radiation oncology. She joined Radiation Oncology Associates in 2022. Dr. Gao is trained in all aspects of radiation oncology, and her practice focuses on the treatment of all types of cancers with an additional focus on the treatment of breast, gynecological, and head and neck malignancies. Dr. Gao grew up in California and attended California State University in Los Angeles through the early entrance program, graduating magna cum laude with a degree in biochemistry. She went on to receive her medical degree from Yale School of Medicine in New Haven, CT, where she was a recipient of the Hirsch and Hsiung Fellowship for medical research. She completed her radiation oncology residency at Yale and served as chief resident. Dr. Gao has experience across a variety of treatment modalities including intensity-modulated radiation therapy, volumetric modulated arc therapy, stereotactic body radiotherapy, Gamma Knife radiosurgery, gynecologic brachytherapy, total skin electron therapy and orthovoltage therapy. During her training, Dr. Gao’s research endeavors focused on using data science to further personalize the treatment of cancer patients. She has experience creating and managing clinical databases, performing advanced statistical analyses, and building supervised machine learning models. She has given multiple oral presentations at national meetings and has authored numerous peer-reviewed publications, book chapters and editorials. Dr. Gao sees patients at Inova Schar Cancer Institute in Fairfax, VA, and at Potomac Radiation Oncology in Woodbridge, VA. Outside the clinic, Dr. Gao enjoys reading, listening to music, trying new recipes and spending time with family. Dr. Gao is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Metastatic Brain Tumor, Prostate Cancer, Familial Prostate Cancer, and Lymphadenectomy.

Dr. Gopal Bajaj is the President of Radiation Oncology Associates, PC, and the emeritus Chairman and Medical Director of the Department for Advanced Radiation Oncology and Proton Therapy for Inova Schar Cancer Institute, having served in this role from 2014 to 2020. Prior to joining the radiation oncology practice at Inova Fairfax Hospital, he was an instructor in radiation oncology, medical oncology, and otolaryngology head and neck surgery at Johns Hopkins Hospital. His clinical focus and academic interests center on providing high level, multidisciplinary treatment to patients with head and neck malignancies, educating the next generation of medical specialists, exploring novel mechanisms of radiation-associated toxicity management, and working with emerging technologies in radiation oncology. His additional area of interest includes radiation therapy for benign disease, with a specific focus on Dupuytren’s and Ledderhose diseases. Dr. Bajaj oversees one of the nation’s busiest practices for the treatment of Dupuytren’s and Ledderhose diseases with radiotherapy and is actively involved in research, physician training and patient advocacy for these conditions. He presently serves as an Associate Professor of Radiation Oncology for the University of Maryland School of Medicine, Virginia Commonwealth University School of Medicine and the Uniformed Services University of the Health Sciences. Dr. Bajaj was raised in Overland Park, KS, and graduated with honors from the University of Kansas, receiving dual degrees in biology and genetics. He received his medical degree from the University of Kansas School of Medicine, where he was elected to the Alpha Omega Alpha Medical Honor Society. He has also performed cancer research at the Otto-von-Guericke Universität in Magdeburg, Germany, and gastrointestinal oncology training at the University of Amsterdam’s Academish Medisch Centrum. He went on to complete an internal medicine internship at Harvard. Dr. Bajaj is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, Breast Cancer, and Metastatic Brain Tumor.

Mustafa Abugideiri is a Radiation Oncologist practicing medicine in Fairfax, Virginia. Dr. Abugideiri is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Dr. Tobias Chapman is a specialty care physician board certified in radiation oncology. He joined Inova Schar Cancer Institute in 2019 with more than eight years of clinical experience. Prior to joining Inova Schar, he served as faculty at Harvard. Dr. Chapman is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, HER-2 Positive Breast Cancer, and Metastatic Brain Tumor.

Dr. Stella Hetelekidis is a specialty care physician board certified in radiation oncology. She joined Inova Health System in 1999 and has been practicing since 1993.Prior to joining Inova, Dr. Hetelekidis practiced at Duke University Hospital in Durham, NC, and the Brigham and Women’s Hospital and Dana Farber Cancer Institute in Boston, MA.Dr. Hetelekidis specializes in breast and gynecologic cancers. She believes in treating every patient like a family member. She helps her patients understand their diagnoses and options, and works together with the patient and her fellow physicians to develop a treatment plan. Dr. Hetelekidis is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Endometrial Cancer, Angiosarcoma, and HER-2 Positive Breast Cancer.

Adriana Sheridan is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Sheridan is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, Pediatric Low-Grade Glioma (pLGG), and Glioma.

Cheng-chia Wu is a Radiation Oncologist practicing medicine in Fairfax, Virginia. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioma, Gliomatosis Cerebri, and Glioblastoma.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Breast Cancer, and Familial Pancreatic Cancer. Dr. Croog is board certified in American Board Of Radiology.

Matthew Ladra, M.D., M.P.H., leads the dedicated pediatric team for the Johns Hopkins Proton Therapy Center and is the director of pediatric radiation oncology for the Johns Hopkins Kimmel Cancer Center, a clinical collaboration with Children’s National Hospital, where Dr. Ladra serves as faculty in the department of pediatric oncology. He is also an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins School of Medicine. Listen Dr. Ladra's Cancer Matters podcast episode to learn more about his work. Previously, Dr. Ladra served as the director of pediatric radiation at the Provision Center for Proton Therapy in Tennessee. He also completed a 2-year fellowship in pediatric proton therapy at the Massachusetts General Hospital’s Francis H. Burr Proton Center. Dr. Ladra is one of a handful of radiation oncologists whose research and clinical efforts focus exclusively on pediatric patients. He is frequently invited to speak on pediatric radiation oncology topics internationally and across the U.S. and has published extensively on the subject through original research book chapters and review articles. Dr. Ladra’s research efforts focus mainly on pediatric rhabdomyosarcoma treatment, early phase clinical trials involving radiation and non-chemotherapeutic agents, and reducing neurocognitive toxicity for pediatric brain tumor patients. LinkedIn https://www.linkedin.com/in/matthew-ladra-3094a316. Dr. Ladra is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Muscle Invasive Bladder Cancer, Adult Soft Tissue Sarcoma, and Ependymoma. Dr. Ladra is board certified in American Board Of Radiology.

John Heiss is a Neurosurgery provider practicing medicine in Bethesda, Maryland. Dr. Heiss is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation Type 2, Syringomyelia, Chiari Malformation, Laminectomy, and Posterior Fossa Decompression.

Deborah Citrin is a Radiation Oncologist practicing medicine in Bethesda, Maryland. Dr. Citrin is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Pulmonary Fibrosis, Bone Tumor, Anal Cancer, and Prostatectomy.